10-05/06 :: May/June 2010
nanotimes
Companies Facts
in 2010. We are reaching out for partner ships in the US to scale up volume production in 2011. We currently offer 160mAh/g NCM composite cathode material in two versions with different particle sizes and tap densities for customers in P-HEV, HEV, EV and consumer applications, working with a manufac- turing partner in Asia.”
http://www.nanoexa.com
N
anogate (N7G) already presented two product lines with expanded and improved products
and functionalities at the Hannover Tradeshow 2010: Innovative UV protection coatings for glass used in interiors (
pro.Glass®
© NanoLumens barrier UV 401) and
scratchproof antifingerprint coatings for stainless steel (permaSeal metal 120).
At the international tradeshow for Surfaces & Coa- tings (O&S) in Stuttgart, a newly developed UV- hardening coating for plastic plates or slabs was now introduced. In cooperation with one of the largest coating service providers for finishing polycarbonate and acrylic plates and slabs, a process was developed that makes it possible to apply the material onto a variety of different types of plastic without further pretreatments using UV-hardening. The strengths of this innovation are characterized by scratch resi- stance, easy cleaning, and low process or production costs. Nanogate has completed an increase in capital a short while ago. The company bought a share of 25.1% as well as an option for the majority in the company sarastro GmbH, Germany, in cash and shares.
http://www.nanogate.com T
wo NanoLumens flexible video displays joined fast cars and fashion in April in the famous win-
dows of Macy’s. The displays arrived at the flagship New York Herald Square store as part of a two-week promotion of IZOD’s sponsorship of IndyCar racing, said the company.
http://www.nanolumens.com http://www.digitalsignageexpo.net/DNNArticleMa-
ster/DNNArticleView/tabid/78/smid/400/ArticleID/3191/ reftab/548/
Default.aspx
N
anoString Technologies, Inc., a privately held life sciences company marketing a comple-
te solution for detecting and counting large sets of target molecules in biological samples, announced the launch of its early access program for a unique new solution that detects copy number variation in human genomic samples. Discovery technologies for detecting CNVs can be subject to considerable false-positive rates. As a result, detected variants of interest are generally validated by real-time quanti- tative PCR (qPCR). This technique, however, is labor intensive and not readily scalable for validating or
31
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83